OncoPrecision logo

OncoPrecision jobs and careers

New York, NY, United States

About OncoPrecision

OncoPrecision is a precision oncology company engineering first-in-class ADCs and bispecific antibodies for hard-to-treat cancers. We start where other drugs fail — studying how cancer cells evade treatment — then engineer precision therapeutics to exploit those vulnerabilities. By combining Patient Micro-Avatars™ (translational patient-derived ex vivo phenotypic models) with AI-driven target validation, our discovery engine surfaces biology that population-level datasets miss — giving every program a structural advantage from day one.

Founded in 2020 by Tarek Ali Zaki.

Founded
2020
Employees
11 to 50
Total funding
$4.2M
Headquarters
New York

Leadership

The top of OncoPrecision's org chart, with how many people report into each leader.

TZPhoto of Tarek Ali Zaki

Tarek Ali Zaki

Co-Founder & CEO

10 reports

GSPhoto of Gastón Soria

Gastón Soria

Co-Founder & CSO

5 reports

CRPhoto of Candelaria Llorens De Los Ríos

Candelaria Llorens De Los Ríos

Co-Founder & Head of Operations

1 report

GGPhoto of Gerardo Gatti

Gerardo Gatti

Co-Founder & Head of Clinical Research

FRPhoto of Federico Rusculleda

Federico Rusculleda

Admin Manager